GO:0032731 positive regulation of interleukin-1 beta production: Inflammatory Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0032731 describes any process that activates or increases the frequency, rate, or extent of interleukin-1 beta (IL-1β) production, including its biosynthesis and secretion.
• IL-1β is a potent pro-inflammatory cytokine produced primarily by blood monocytes and tissue macrophages, and its overproduction drives multiple chronic inflammatory diseases.
• Positive regulation of IL-1β production involves two distinct signals: a priming signal that induces pro-IL-1β synthesis and an activation signal that triggers inflammasome-mediated cleavage and release.
• Dysregulated IL-1β production is causally linked to psoriasis, osteoarthritis, multiple myeloma, sepsis-induced cardiomyopathy, and diabetic nephropathy.
• Key regulatory nodes include NLRP3 inflammasome components, SIRT1/GPX4 signaling, TREM2 in macrophages, and CARD8, which can be evaded during HIV-1 assembly.
• CRISPR knockout, point-mutation, knock-in, and overexpression models are essential for dissecting causal roles of candidate genes in IL-1β regulation.
Description
Interleukin-1 beta (IL-1β) is a master pro-inflammatory cytokine whose production must be tightly controlled to avoid tissue damage. The Gene Ontology term GO:0032731, positive regulation of interleukin-1 beta production, captures all biological processes that activate or increase the frequency, rate, or extent of IL-1β production. This includes transcriptional induction of the IL1B gene, inflammasome-mediated proteolytic maturation, and unconventional secretion of the mature cytokine. Researchers study this term because IL-1β overproduction is a central driver of chronic inflammatory and autoimmune conditions, and understanding its positive regulation offers therapeutic entry points. The production of human IL-1β by blood monocytes was recognized decades ago as a key source of this cytokine, establishing monocytes and macrophages as primary cellular models. More recent work has expanded the regulatory landscape to include keratinocytes, renal tubular cells, and macrophage subsets in diverse tissues.
positive regulation of interleukin-1 beta production At A Glance
| GO ID | GO:0032731 |
|---|---|
| GO term | positive regulation of interleukin-1 beta production |
| Ontology | biological_process |
| Synonym | activation of interleukin-1 beta production; positive regulation of IL-1 beta production; positive regulation of interleukin-1 beta biosynthetic process; positive regulation of interleukin-1 beta secretion; stimulation of interleukin-1 beta production; up regulation of interleukin-1 beta production; up-regulation of interleukin-1 beta production; upregulation of interleukin-1 beta production |
| Major function | Increases the frequency, rate, or extent of IL-1β production, including biosynthesis and secretion |
| Primary cell types | Blood monocytes, tissue macrophages, keratinocytes, renal tubular cells |
| Key molecular players | NLRP3 inflammasome, caspase-1, SIRT1, GPX4, TREM2, CARD8 |
| Disease relevance | Psoriasis, osteoarthritis, multiple myeloma, sepsis-induced cardiomyopathy, diabetic nephropathy |
What Is GO:0032731?
GO:0032731 is defined as any process that activates or increases the frequency, rate, or extent of interleukin-1 beta production. In practical terms, it encompasses molecular events that elevate the amount of IL-1β protein available for secretion, whether by boosting IL1B gene transcription, enhancing pro-IL-1β processing by caspase-1, or promoting the release of mature IL-1β from cells.
Why Is positive regulation of interleukin-1 beta production Important in Cell Biology?
Positive regulation of IL-1β production is critically important because IL-1β is one of the most potent endogenous pyrogens and inflammatory mediators, and its excessive production underlies the pathogenesis of numerous acute and chronic diseases. In multiple myeloma, IL-1β produced by the bone marrow microenvironment promotes tumor growth and bone destruction, making it a therapeutic target. In psoriasis, autophagy-based unconventional secretion of HMGB1 by keratinocytes amplifies IL-1β-driven skin inflammation. In osteoarthritis, IL-1β-tailored exosome cargo can remodel the proinflammatory microenvironment and support cartilage regeneration, highlighting the therapeutic potential of modulating this process. Understanding the positive regulation of IL-1β production is therefore essential for developing targeted anti-inflammatory strategies.
• IL-1β is a central mediator of innate immunity and inflammation, and its positive regulation determines the magnitude of inflammatory responses.
• Dysregulated IL-1β production contributes to autoimmune and autoinflammatory diseases, including psoriasis and osteoarthritis.
• In multiple myeloma, IL-1β supports tumor cell growth and bone destruction, linking this GO term to cancer biology.
• Sepsis-induced cardiomyopathy involves ferroptosis regulated through SIRT1/GPX4, with IL-1β as a downstream inflammatory effector.
• Diabetic nephropathy features TREM2+ macrophage-mediated repression of IL-1β, showing that negative regulation of this process is protective.
• HIV-1 can evade CARD8 activation during assembly, revealing pathogen strategies to modulate IL-1β production.
• Platelet-rich plasma therapy reduces inflammation by regulating M1/M2 macrophage polarization and IL-1β levels in knee osteoarthritis.
• Targeting positive regulators of IL-1β production offers opportunities for precision anti-cytokine therapy.
What Happens During positive regulation of interleukin-1 beta production?
Priming and Transcriptional Induction of IL1B
In simple terms: First, cells receive a signal that tells them to make more IL-1β mRNA and protein.
The first step in positive regulation of IL-1β production is often transcriptional priming, where pattern recognition receptors or cytokine signals induce NF-κB-dependent transcription of the IL1B gene, leading to accumulation of inactive pro-IL-1β in the cytoplasm. This priming step is essential because most cells do not constitutively express large amounts of pro-IL-1β, and without it, subsequent activation signals cannot generate mature cytokine.
Inflammasome Activation and Caspase-1 Cleavage
In simple terms: A molecular platform called the inflammasome activates an enzyme that cuts pro-IL-1β into its active form.
Following priming, activation of the NLRP3 inflammasome or related platforms recruits and activates caspase-1, which proteolytically cleaves pro-IL-1β into mature IL-1β. This cleavage is a critical positive regulatory event because only the mature form is biologically active and capable of binding the IL-1 receptor. CARD8 is another inflammasome sensor that can trigger caspase-1 activation, and its evasion by HIV-1 during assembly represents a pathogen strategy to limit IL-1β production.
Unconventional Secretion of Mature IL-1β
In simple terms: The active IL-1β leaves the cell through a non-classical route that does not use the standard secretion machinery.
Mature IL-1β lacks a signal peptide and is secreted via unconventional mechanisms, including autophagy-based secretion and exosome release. In psoriatic keratinocytes, autophagy-based unconventional secretion of HMGB1 amplifies the inflammatory cascade that drives IL-1β production. In osteoarthritis, IL-1β-tailored exosome cargo can modulate the inflammatory microenvironment, demonstrating that secretion is a regulated and targetable step.
Amplification by Macrophage Polarization and Tissue Microenvironment
In simple terms: The surrounding tissue and immune cell states can further boost or restrain IL-1β production.
Macrophage polarization states strongly influence IL-1β production: M1-polarized macrophages are major producers, while M2-polarized macrophages are associated with reduced IL-1β and tissue repair. In knee osteoarthritis, platelet-rich plasma relieves inflammation by shifting macrophage polarization from M1 to M2, thereby reducing IL-1β levels. In diabetic nephropathy, TREM2+ macrophages repress IL-1β-mediated CD36 expression in renal tubules, illustrating how specific macrophage subsets can negatively regulate this process.
Metabolic and Redox Control of IL-1β Production
In simple terms: Cellular metabolism and oxidative stress pathways can dial IL-1β production up or down.
The SIRT1/GPX4 axis regulates ferroptosis and inflammation in sepsis-induced cardiomyopathy, with IL-1β as a downstream effector of this pathway. Stachydrine alleviates sepsis-induced cardiomyopathy by inhibiting ferroptosis via SIRT1/GPX4 regulation, indirectly reducing IL-1β-mediated injury. These findings place metabolic and redox sensors upstream of positive regulation of IL-1β production, offering additional nodes for therapeutic intervention.
Key Genes Involved in GO:0032731 positive regulation of interleukin-1 beta production
The following genes and proteins are experimentally implicated in the positive regulation of IL-1β production, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| IL1B | Encodes pro-IL-1β, the precursor of mature IL-1β | Central to all studies of IL-1β production |
| NLRP3 | Inflammasome sensor that activates caspase-1 | Key positive regulator of IL-1β maturation |
| CASP1 | Cleaves pro-IL-1β into mature active cytokine | Essential for IL-1β bioactivity |
| CARD8 | Inflammasome sensor triggering caspase-1 activation | Evaded by HIV-1 during assembly to limit IL-1β |
| HMGB1 | Autophagy-based unconventional secretion mediator | Amplifies psoriatic skin inflammation and IL-1β |
| SIRT1 | Deacetylase regulating ferroptosis and inflammation | Modulates IL-1β in sepsis-induced cardiomyopathy |
| GPX4 | Glutathione peroxidase inhibiting ferroptosis | Downstream of SIRT1, affects IL-1β-mediated injury |
| TREM2 | Macrophage receptor repressing IL-1β-mediated CD36 | Protective in diabetic nephropathy |
| CD36 | Scavenger receptor induced by IL-1β | Mediates lipid accumulation in renal tubules |
| IL1R1 | Receptor for IL-1β | Mediates downstream inflammatory signaling |
| NFKB1 | Transcription factor driving IL1B expression | Priming of IL-1β production |
| P2RX7 | ATP-gated ion channel activating NLRP3 | Second signal for inflammasome activation |
| GSDMD | Gasdermin D pore-forming protein for IL-1β release | Unconventional secretion effector |
| ATG5 | Autophagy machinery component | Required for autophagy-based IL-1β secretion |
| MAP1LC3B | Autophagosome marker | Tracks unconventional secretion of IL-1β |
| MMP13 | Matrix metalloproteinase induced by IL-1β | Cartilage degradation in osteoarthritis |
| ADAMTS5 | Aggrecanase induced by IL-1β | Cartilage matrix breakdown in osteoarthritis |
How Is positive regulation of interleukin-1 beta production Regulated?
Positive regulation of IL-1β production is controlled at multiple levels. Transcriptional priming via NF-κB induces pro-IL-1β synthesis. Inflammasome assembly and caspase-1 activation provide a second checkpoint. Metabolic and redox pathways, including SIRT1/GPX4, modulate the threshold for IL-1β release. Macrophage polarization states and tissue-specific signals, such as TREM2 in diabetic nephropathy, can repress IL-1β production. Additionally, autophagy-based unconventional secretion regulates the extracellular availability of mature IL-1β.
positive regulation of interleukin-1 beta production and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| HMGB1 | Psoriasis | Keratinocyte-specific knockout or overexpression |
| IL1B | Osteoarthritis | Chondrocyte knockout or IL-1β-treated cartilage explants |
| IL1B | Multiple myeloma | Myeloma cell lines and bone marrow co-cultures |
| SIRT1 | Sepsis-induced cardiomyopathy | Cardiomyocyte-specific knockout or SIRT1 activator treatment |
| TREM2 | Diabetic nephropathy | Macrophage-specific knockout in diabetic mouse models |
Psoriasis and Skin Inflammation
In psoriasis, autophagy-based unconventional secretion of HMGB1 by keratinocytes plays a pivotal role in skin inflammation by amplifying IL-1β production. This links GO:0032731 directly to the pathogenesis of psoriatic lesions and suggests that targeting HMGB1 secretion could reduce IL-1β-driven inflammation.
Osteoarthritis and Cartilage Degeneration
IL-1β is a major catabolic factor in osteoarthritis, inducing matrix metalloproteinases and aggrecanases that degrade cartilage. Remodeling the proinflammatory microenvironment through IL-1β-tailored exosome cargo can regulate inflammation and support cartilage regeneration, demonstrating the therapeutic relevance of modulating this GO term. Platelet-rich plasma relieves inflammation and pain by regulating M1/M2 macrophage polarization, thereby reducing IL-1β in knee osteoarthritis.
Multiple Myeloma and Bone Disease
In multiple myeloma, IL-1β produced in the bone marrow microenvironment promotes tumor cell growth and osteoclast activation, contributing to lytic bone lesions. The role of IL-1β in the pathogenesis of multiple myeloma has been recognized for decades, and targeting IL-1β production remains a potential therapeutic strategy.
Sepsis-Induced Cardiomyopathy and Diabetic Nephropathy
Sepsis-induced cardiomyopathy involves ferroptosis regulated by SIRT1/GPX4, with IL-1β as a downstream mediator of cardiac injury. In diabetic nephropathy, TREM2+ macrophages alleviate renal tubule lipid accumulation and ferroptosis by repressing IL-1β-mediated CD36 expression, highlighting a protective role for negative regulation of IL-1β production.
From positive regulation of interleukin-1 beta production-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X positively regulate IL-1β production? | CRISPR knockout in monocytes or macrophages followed by LPS/ATP stimulation |
| Does a specific point mutation in gene X alter IL-1β secretion? | CRISPR point-mutation knock-in in cell lines |
| Does tagging endogenous gene X reveal its role in inflammasome assembly? | Tagged knock-in with fluorescent or epitope tag |
| Does overexpression of gene X amplify IL-1β production? | Lentiviral or CRISPR activation overexpression |
| Which macrophage subsets produce IL-1β in vivo? | Reporter mice or single-cell RNA-seq in disease models |
| Can modulating gene X reduce IL-1β-driven pathology? | Preclinical disease models with CRISPR-edited cells |
How to Study the positive regulation of interleukin-1 beta production Process
| Method | What It Measures | Typical Application |
|---|---|---|
| ELISA | Mature IL-1β protein in supernatants or serum | Screening for positive regulators of IL-1β production |
| Western blot | Pro-IL-1β and cleaved caspase-1 levels | Distinguishing priming from inflammasome activation |
| RNA-seq | Transcriptional changes in IL1B and inflammatory genes | Identifying upstream regulators |
| Autophagy flux assay | LC3B lipidation and autophagosome formation | Studying unconventional IL-1β secretion |
| Flow cytometry | Intracellular pro-IL-1β and surface markers | Characterizing macrophage subsets |
| Caspase-1 activity assay | Enzymatic activity of caspase-1 | Confirming inflammasome activation |
| Exosome isolation and characterization | IL-1β cargo in extracellular vesicles | Therapeutic modulation in osteoarthritis |
| Ferroptosis assays | Lipid peroxidation and GPX4 activity | Linking metabolic stress to IL-1β production |
ELISA and Cytokine Profiling
Quantification of mature IL-1β in culture supernatants or serum by ELISA is the standard method to assess positive regulation of IL-1β production. This method measures the cumulative output of the entire pathway, from transcription to secretion, and is widely used in macrophage and monocyte studies.
Western Blot and Caspase-1 Activation Assays
Western blotting for pro-IL-1β and mature IL-1β, along with detection of cleaved caspase-1, distinguishes transcriptional priming from inflammasome activation. These assays are essential for pinpointing the step at which a candidate gene acts.
RNA-seq and Transcriptomics
RNA sequencing reveals transcriptional changes in IL1B and related inflammatory genes following genetic or pharmacological perturbations. This approach helps identify upstream regulators and co-expressed gene networks that drive IL-1β production.
Imaging and Autophagy Flux Assays
Fluorescence microscopy and autophagy flux assays using LC3B reporters track unconventional secretion of IL-1β and the involvement of autophagy machinery. These methods are particularly useful for studying HMGB1-mediated secretion in keratinocytes.
How CRISPR Can Be Used to Study GO:0032731 positive regulation of interleukin-1 beta production
Knockout
CRISPR knockout of candidate genes such as NLRP3, CASP1, or HMGB1 in monocytes, macrophages, or keratinocytes allows researchers to test whether the gene is required for positive regulation of IL-1β production. Loss-of-function studies are the gold standard for establishing necessity in the pathway.
Point Mutation
CRISPR point-mutation knock-in can introduce specific amino acid substitutions to dissect domain functions, such as caspase-1 catalytic residues or CARD8 sensor domains, without abolishing protein expression. This approach is valuable for separating scaffolding from enzymatic functions in IL-1β regulation.
Knock-in
Tagged knock-in of endogenous genes with fluorescent or epitope tags enables real-time tracking of protein localization and interactions during inflammasome assembly and IL-1β secretion. Knock-in reporter cell lines are also useful for high-content screening of modulators.
Overexpression
CRISPR activation or lentiviral overexpression of candidate genes such as SIRT1, GPX4, or TREM2 can test sufficiency for altering IL-1β production. Overexpression models are particularly informative when combined with disease-relevant stimuli like LPS/ATP or high glucose.
How EDITGENE Supports positive regulation of interleukin-1 beta production Research
Researchers studying positive regulation of interleukin-1 beta production-related genes often need to determine whether a candidate gene is causally involved in IL-1β synthesis, maturation, or secretion. EDITGENE provides end-to-end CRISPR cell model services to accelerate this discovery process.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of interleukin-1 beta production research.
Frequently Asked Questions About positive regulation of interleukin-1 beta production
What is GO:0032731?
GO:0032731 is the Gene Ontology term for positive regulation of interleukin-1 beta production, defined as any process that activates or increases the frequency, rate, or extent of IL-1β production.
What genes are involved in positive regulation of interleukin-1 beta production?
Key genes include IL1B, NLRP3, CASP1, CARD8, HMGB1, SIRT1, GPX4, TREM2, and CD36, among others.
How is IL-1β production positively regulated?
It is positively regulated through transcriptional priming of IL1B, inflammasome-mediated caspase-1 cleavage of pro-IL-1β, and unconventional secretion of mature cytokine.
What diseases are linked to excessive IL-1β production?
Excessive IL-1β production is linked to psoriasis, osteoarthritis, multiple myeloma, sepsis-induced cardiomyopathy, and diabetic nephropathy.
What cell types produce IL-1β?
Blood monocytes and tissue macrophages are major producers, but keratinocytes and renal tubular cells can also contribute in specific disease contexts.
How can I study positive regulation of IL-1β production in the lab?
Common methods include ELISA for mature IL-1β, Western blot for pro-IL-1β and caspase-1, RNA-seq, autophagy flux assays, and CRISPR knockout or knock-in models.
What is the role of the NLRP3 inflammasome in IL-1β production?
The NLRP3 inflammasome activates caspase-1, which cleaves pro-IL-1β into its mature active form, making it a central positive regulator.
Can CRISPR be used to study IL-1β regulation?
Yes, CRISPR knockout, point-mutation knock-in, tagged knock-in, and overexpression models are widely used to dissect causal roles of genes in IL-1β production.
What is the role of TREM2 in IL-1β production?
TREM2+ macrophages repress IL-1β-mediated CD36 expression in diabetic nephropathy, indicating a protective role in limiting IL-1β-driven lipid accumulation.
How does SIRT1 affect IL-1β production?
SIRT1 regulates ferroptosis via GPX4, and this pathway modulates IL-1β-mediated injury in sepsis-induced cardiomyopathy.
Conclusion
GO:0032731, positive regulation of interleukin-1 beta production, is a central biological process in inflammatory signaling, encompassing transcriptional priming, inflammasome activation, and unconventional secretion of IL-1β. Its dysregulation contributes to psoriasis, osteoarthritis, multiple myeloma, sepsis-induced cardiomyopathy, and diabetic nephropathy. CRISPR-based cell models are indispensable for dissecting the causal roles of individual genes in this pathway, and EDITGENE provides comprehensive services to support such research.
References
- 1. Wang Z et al.. 2021. Autophagy-based unconventional secretion of HMGB1 by keratinocytes plays a pivotal role in psoriatic skin inflammation.. Autophagy 17(2):529-552 PMID: 32019420
- 2. Chen M et al.. 2025. Remodeling the Proinflammatory Microenvironment in Osteoarthritis through Interleukin-1 Beta Tailored Exosome Cargo for Inflammatory Regulation and Cartilage Regeneration.. ACS Nano 19(4):4924-4941 PMID: 39848926
- 3. Tao L et al.. 2025. Stachydrine Alleviates Sepsis-Induced Cardiomyopathy by Inhibiting Ferroptosis via Regulating SIRT1/GPX4 Pathway.. Dose Response 23(3):15593258251377710 PMID: 40919231
- 4. Newton RC. 1990. The production of human interleukin-1 beta by blood monocytes.. Prog Clin Biol Res 349:217-28 PMID: 2204930
- 5. Xu J et al.. 2025. Platelet-rich plasma relieves inflammation and pain by regulating M1/M2 macrophage polarization in knee osteoarthritis rats.. Sci Rep 15(1):12805 PMID: 40229323
- 6. Wang X et al.. 2025. Trem2+ Macrophages Alleviate Renal Tubule Lipid Accumulation and Ferroptosis in Diabetic Nephropathy by Repressing IL-1β-Mediated CD36 Expression.. Diabetes 74(12):2231-2248 PMID: 41042607
- 7. Lust JA et al.. 1999. The role of interleukin-1 beta in the pathogenesis of multiple myeloma.. Hematol Oncol Clin North Am 13(6):1117-25 PMID: 10626139
- 8. Hughes IK et al.. 2025. Evasion of CARD8 activation during HIV-1 assembly.. Sci Adv 11(46):eadz1069 PMID: 41223282
